Results 71 to 80 of about 6,278 (218)
Clinical Obesity, Volume 16, Issue 1, February 2026.ABSTRACT The aim of this systematic literature review (SLR) of reviews was to update the evidence, established in a 2017 SLR, on the impact of obesity and weight loss by various interventions on health‐related quality of life (HRQoL). In total, eight SLRs and/or meta‐analyses published since 2017 were identified. The results consistently demonstrated a
Tone Nygaard Flølo +3 more
wiley +1 more source
Early and late complications of bariatric operation. [PDF]
, 2018 Weight loss surgery is one of the fastest growing segments of the surgical discipline. As with all medical procedures, postoperative complications will occur. Acute care surgeons need to be familiar with the common problems and their management. Although
Beekley, Alec +3 more
core +1 more source
Anxiety and depression in association with morbid obesity: changes with improved physical health after duodenal switch [PDF]
, 2010 Background Patients with morbid obesity have an increased risk for anxiety and depression. The "duodenal switch" is perhaps the most effective obesity surgery procedure for inducing weight loss.
Andersen, John Roger +5 more
core +2 more sources
A Rational Approach to Pharmacotherapy in Pregnancy
The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen +2 more
wiley +1 more source
The effect of bariatric surgeries on nonalcoholic fatty liver disease
The Saudi Journal of Gastroenterology, 2014 Objective: A review of published data addressing hepatic histopathological, metabolical, and functional changes following gastric banding, sleeve gastrectomy, gastric bypass surgery, and biliopancreatic with duodenal switch surgeries on nonalcoholic ...
Mazen Hassanian +6 more
doaj +1 more source
The influence of bypass procedures and other anatomical changes in the gastrointestinal tract on the oral bioavailability of drugs [PDF]
, 2013 The gastrointestinal (GI) tract plays an important role in the absorption of orally administered drugs. However, in some cases the anatomy of the GI tract is changed due to GI surgery, which has the potential of influencing drug bioavailability.
Boussery, Koen +2 more
core +2 more sources
Journal of Experimental Orthopaedics, Volume 13, Issue 1, January 2026.Abstract Purpose Obesity is often considered a relative contraindication to total hip arthroplasty (THA) due to presumed increased perioperative and postoperative risk. Consequently, obese patients are often advised to lose weight prior to THA. However, the effect of preoperative weight loss on THA outcomes remains uncertain.
Nils Meissner +6 more
wiley +1 more source
Характеристика закономірностей змін показників протеїнового обміну у пацієнтів з морбідним ожирінням після оперативного лікування на тлі зниження маси тіла [PDF]
, 2018 За прогнозами, до 2018 року вже 2,5 млрд та 750 млн людей будуть мати надлишкову масу тіла та ожиріння відповідно, які негативно впливають на якість і тривалість життя хворих. Проаналізовано результати баріатичного втручання та динаміку зміни маси тіла
Дука, Р.В.
core
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? [PDF]
, 2013 The number of bariatric surgical procedures performed has increased dramatically. This review discusses the clinical and physiological changes, and in particular, the mechanisms behind weight loss and glycaemic improvements, observed following the ...
le Roux, CW, Miras, AD
core +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 358-378, January 2026.Abstract Aims We aimed at comparing different approved strategies (obesity management medications—OMM, endoscopic bariatric procedures—EBP, and metabolic bariatric surgery—MBS) with lifestyle intervention/placebo/no therapy (LSI/Pbo/NT) for the treatment of different BMI‐based classes of obesity (i.e., overweight—BMI: 25–29.9 kg/m2; class I—BMI: 30–34 ...
Rocco Barazzoni +10 more
wiley +1 more source